Tesamorelin Peptide research-grade
Tesamorelin Peptide
$47.00 $146.00Price range: $47.00 through $146.00 Select options

Tesamorelin Peptide

Price range: $47.00 through $146.00

Research-grade Tesamorelin Peptide is a stabilized GHRH analog used in laboratory growth hormone–axis and metabolic peptide research. It is supplied for pre-clinical research into GHRH pathway characterization and controlled endocrine models—not for clinical, veterinary, or consumer use.

For Research Use Only. Not for human use.

BULK PRICING

5–10
$0.00 each
Save 0%
11–20
$0.00 each
Save 0%
21+
$0.00 each
Save 0%

For Research Use Only — Not for Human Consumption
 

Free shipping on all orders over $200 (US)

  • 99% Purity – Third-Party Tested
  • Fast & Reliable Shipping
Guaranteed Checkout

For Research Use Only. Not for human use.

Tesamorelin Peptide laboratory catalog material

Overview

Research-grade Tesamorelin Peptide is a stabilized GHRH analog used in growth hormone–axis and metabolic peptide research. This catalog entry is designated for structured laboratory programs examining GHRH pathway characterization and controlled endocrine models—not for clinical, veterinary, or consumer use.

Laboratories select Tesamorelin Peptide when they need a defined input for studies of GHRH pathway characterization and controlled endocrine models. Investigators typically deploy this material in cell-based or cell-free formats, assay development, and pathway-oriented model work under institutional SOPs.

This entry is positioned for qualified laboratory purchasing where batch metadata and label clarity matter. Investigators keep Tesamorelin Peptide inside validated SOPs covering reconstitution, aliquotting, and cold storage while maintaining research-use-only custody from receipt through disposal.

Material Snapshot

Tesamorelin Peptide is offered as a laboratory catalog reagent intended strictly for structured research environments.

Science teams source this listing when they need reliable vial identification, uniform labels, and paperwork that supports repeatable experimental series.

Research-use packaging helps receiving and laboratory staff connect order records to the sealed unit on arrival.

Laboratory Applications for Tesamorelin Peptide

Projects using Tesamorelin Peptide commonly emphasize cell-free or cell-based assays, analytical method build-out, and pathway-oriented model work.

Operators verify batch metadata ahead of setup so runs remain auditable across replicates and partner labs.

Peer-reviewed references may guide initial experimental windows. Every facility should still confirm performance on its own readers, plate formats, and reagent chemistry.

Limited-scale pilots are recommended before expanding panel size, particularly when signal windows or incubation timing are still being tuned.

Catalog Specifications

Notable listing attributes for this reagent include:

  • Laboratory-grade supply designated for investigational bench use only
  • Research channel labeling suited to institutional purchasing workflows
  • Appropriate for assay construction and side-by-side method comparisons
  • Lot documentation supplied when available for the shipped batch

Bench Handling Guidance

Intake Verification

Prior to opening Tesamorelin Peptide, match the vial marking to the purchase record and shipment checklist.

Hold shipper cartons until identity confirmation finishes, and notify procurement if seals appear compromised before any bench work proceeds.

Solution Prep and Aliquots

Process this reagent under your organization’s SOPs covering mass determination, solvent addition, splitting, and cold storage.

Log batch codes in the lab notebook before dissolution. Confirm solvent choice and hold temperature against your validated procedure.

Stage buffers and disposables before breaking the seal to minimize open-vial time. Mark leftover aliquots with prepared date, vehicle, and strength for later replicates.

Traceability Practices

Maintain custody notes with stock checks whenever material relocates between cold storage and workstations.

Assign clean tools and balances per catalog item to limit carryover. Plan thaw events deliberately instead of cycling the same aliquot repeatedly.

Secondary trays lower spill exposure during multi-step prep. Record cold-chain gaps even if the primary seal stays intact.

Why Research Groups Select Tesamorelin Peptide

Purchasing and laboratory leads frequently prefer this catalog entry because it enables:

  • Explicit research-only marking supporting policy-aligned intake
  • Stable naming and identity cues across multi-batch programs
  • Utility in calibration, screening, and mechanism-focused models
  • Efficient catalog support for scheduling and record-keeping

Protocol Prep and Quality Files

Ahead of experimental series with Tesamorelin Peptide, examine any certificate or quality attachments included with delivery.

Keep protocols inside institutional research boundaries and within the stated research-use scope.

Archive listing paperwork with study files at receipt. That habit preserves continuity when Tesamorelin Peptide appears in later study stages.

Assay Build Notes

Assay construction usually starts with compact pilot plates before full screening arrays.

Capture buffer lot IDs, dwell times, and detector settings together with the reagent batch number.

When outputs depart from prior baselines, reconfirm reconstitution volume and storage history first. Shared instrument logs clarify operator-to-operator differences on identical SOPs.

Stock Control and Onboarding

Refresh electronic inventory as soon as a new lot of Tesamorelin Peptide is opened.

Orienting new personnel on label conventions lowers mix-ups among similar research SKUs. When methods move between facilities, transmit both the SOP text and the lot documentation set.

Discard residual solutions under institutional chemical hygiene policy. Do not redirect research materials to any non-laboratory purpose.

Routine stock reconciliation prevents depleted or out-of-date lots from entering live runs. After confirming assay requirements, review neighboring research listings on this catalog.

For Research Use Only. Not for human or animal use. Not intended to diagnose, treat, cure, or prevent any disease.

Peptide Research

For Research Use Only. Not for human use.

National Science Labs maintains this PubMed (NIH/NLM) citation index for laboratory literature review of the listed compound. A citation’s presence does not expand permitted use beyond controlled research. Each entry uses NSL’s compliance-oriented indexing style.

Showing 44 PubMed records in the National Science Labs literature index. Displaying 10 per page.

  1. NSL literature pointer PMID 31644039 — Tesamorelin laboratory index [PMID: 31644039]

    National Science Labs indexing note for PMID 31644039: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  2. NSL literature pointer PMID 21283099 — Tesamorelin laboratory index [PMID: 21283099]

    National Science Labs indexing note for PMID 21283099: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  3. NSL literature pointer PMID 38905488 — Tesamorelin laboratory index [PMID: 38905488]

    National Science Labs indexing note for PMID 38905488: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  4. NSL literature pointer PMID 21591600 — Tesamorelin laboratory index [PMID: 21591600]

    National Science Labs indexing note for PMID 21591600: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  5. NSL literature pointer PMID 21668043 — Tesamorelin laboratory index [PMID: 21668043]

    National Science Labs indexing note for PMID 21668043: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  6. NSL literature pointer PMID 39813152 — Tesamorelin laboratory index [PMID: 39813152]

    National Science Labs indexing note for PMID 39813152: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  7. NSL literature pointer PMID 22298602 — Tesamorelin laboratory index [PMID: 22298602]

    National Science Labs indexing note for PMID 22298602: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  8. NSL literature pointer PMID 32701508 — Tesamorelin laboratory index [PMID: 32701508]

    National Science Labs indexing note for PMID 32701508: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  9. NSL literature pointer PMID 33756511 — Tesamorelin laboratory index [PMID: 33756511]

    National Science Labs indexing note for PMID 33756511: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  10. NSL literature pointer PMID 22050344 — Tesamorelin laboratory index [PMID: 22050344]

    National Science Labs indexing note for PMID 22050344: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  11. NSL literature pointer PMID 34006921 — Tesamorelin laboratory index [PMID: 34006921]

    National Science Labs indexing note for PMID 34006921: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  12. NSL literature pointer PMID 25358450 — Tesamorelin laboratory index [PMID: 25358450]

    National Science Labs indexing note for PMID 25358450: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  13. NSL literature pointer PMID 36845310 — Tesamorelin laboratory index [PMID: 36845310]

    National Science Labs indexing note for PMID 36845310: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  14. NSL literature pointer PMID 28832410 — Tesamorelin laboratory index [PMID: 28832410]

    National Science Labs indexing note for PMID 28832410: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  15. NSL literature pointer PMID 41545261 — Tesamorelin laboratory index [PMID: 41545261]

    National Science Labs indexing note for PMID 41545261: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  16. NSL literature pointer PMID 19243281 — Tesamorelin laboratory index [PMID: 19243281]

    National Science Labs indexing note for PMID 19243281: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  17. NSL literature pointer PMID 31611038 — Tesamorelin laboratory index [PMID: 31611038]

    National Science Labs indexing note for PMID 31611038: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  18. NSL literature pointer PMID 21516030 — Tesamorelin laboratory index [PMID: 21516030]

    National Science Labs indexing note for PMID 21516030: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  19. NSL literature pointer PMID 24178787 — Tesamorelin laboratory index [PMID: 24178787]

    National Science Labs indexing note for PMID 24178787: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  20. NSL literature pointer PMID 20554713 — Tesamorelin laboratory index [PMID: 20554713]

    National Science Labs indexing note for PMID 20554713: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  21. NSL literature pointer PMID 17086939 — Tesamorelin laboratory index [PMID: 17086939]

    National Science Labs indexing note for PMID 17086939: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  22. NSL literature pointer PMID 31237318 — Tesamorelin laboratory index [PMID: 31237318]

    National Science Labs indexing note for PMID 31237318: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  23. NSL literature pointer PMID 27121785 — Tesamorelin laboratory index [PMID: 27121785]

    National Science Labs indexing note for PMID 27121785: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  24. NSL literature pointer PMID 18690162 — Tesamorelin laboratory index [PMID: 18690162]

    National Science Labs indexing note for PMID 18690162: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  25. NSL literature pointer PMID 25038357 — Tesamorelin laboratory index [PMID: 25038357]

    National Science Labs indexing note for PMID 25038357: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  26. NSL literature pointer PMID 22495074 — Tesamorelin laboratory index [PMID: 22495074]

    National Science Labs indexing note for PMID 22495074: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  27. NSL literature pointer PMID 26457580 — Tesamorelin laboratory index [PMID: 26457580]

    National Science Labs indexing note for PMID 26457580: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  28. NSL literature pointer PMID 25895899 — Tesamorelin laboratory index [PMID: 25895899]

    National Science Labs indexing note for PMID 25895899: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  29. NSL literature pointer PMID 20101189 — Tesamorelin laboratory index [PMID: 20101189]

    National Science Labs indexing note for PMID 20101189: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  30. NSL literature pointer PMID 22926095 — Tesamorelin laboratory index [PMID: 22926095]

    National Science Labs indexing note for PMID 22926095: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  31. NSL literature pointer PMID 28617838 — Tesamorelin laboratory index [PMID: 28617838]

    National Science Labs indexing note for PMID 28617838: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  32. NSL literature pointer PMID 31611037 — Tesamorelin laboratory index [PMID: 31611037]

    National Science Labs indexing note for PMID 31611037: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  33. NSL literature pointer PMID 21115997 — Tesamorelin laboratory index [PMID: 21115997]

    National Science Labs indexing note for PMID 21115997: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  34. NSL literature pointer PMID 22096409 — Tesamorelin laboratory index [PMID: 22096409]

    National Science Labs indexing note for PMID 22096409: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  35. NSL literature pointer PMID 42538058 — Tesamorelin laboratory index [PMID: 42538058]

    National Science Labs indexing note for PMID 42538058: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  36. NSL literature pointer PMID 21687371 — Tesamorelin laboratory index [PMID: 21687371]

    National Science Labs indexing note for PMID 21687371: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  37. NSL literature pointer PMID 42419889 — Tesamorelin laboratory index [PMID: 42419889]

    National Science Labs indexing note for PMID 42419889: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  38. NSL literature pointer PMID 18724445 — Tesamorelin laboratory index [PMID: 18724445]

    National Science Labs indexing note for PMID 18724445: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  39. NSL literature pointer PMID 18828236 — Tesamorelin laboratory index [PMID: 18828236]

    National Science Labs indexing note for PMID 18828236: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  40. NSL literature pointer PMID 17575575 — Tesamorelin laboratory index [PMID: 17575575]

    National Science Labs indexing note for PMID 17575575: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  41. NSL literature pointer PMID 30764032 — Tesamorelin laboratory index [PMID: 30764032]

    National Science Labs indexing note for PMID 30764032: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  42. NSL literature pointer PMID 42139091 — Tesamorelin laboratory index [PMID: 42139091]

    National Science Labs indexing note for PMID 42139091: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  43. NSL literature pointer PMID 17571443 — Tesamorelin laboratory index [PMID: 17571443]

    National Science Labs indexing note for PMID 17571443: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

  44. NSL literature pointer PMID 21695284 — Tesamorelin laboratory index [PMID: 21695284]

    National Science Labs indexing note for PMID 21695284: review the PubMed methods, models, and limitations before citing. Provided solely to support laboratory literature literacy for Tesamorelin.

Continue in PubMed for additional laboratory literature: PubMed search.

Additional information

Weight.125 lbs
Dimensions8 × 7 × .5 in
Size: No selection

5mg, 10mg, 20mg

Keep lyophilized peptides sealed in their original vial, protected from light and humidity, and store at -4°F or colder for optimal long-term stability in research settings; short-term refrigeration at around 39°F suffices for immediate use within weeks, though freezer storage maximizes integrity across extended research timelines.

Frequently Asked Questions

How does National Science Labs describe Tesamorelin Peptide in the catalog?

Tesamorelin Peptide is listed by National Science Labs as a research-designated laboratory material for structured experimental programs involving peptide or related pathway work.

Which laboratory workflows typically reference Tesamorelin?

Research groups reference Tesamorelin when building assays, mapping signaling pathways, or running controlled in-vitro or authorized preclinical model series under institutional SOPs.

Is Tesamorelin Peptide approved or intended for human use?

No. Tesamorelin is strictly intended for research purposes only and is not approved by the FDA for human use.

Is Tesamorelin Peptide FDA-approved for medical or clinical use?

No. Tesamorelin is not approved by the U.S. Food and Drug Administration for any medical, therapeutic, or diagnostic use.

How is Tesamorelin packaged for research intake?

Tesamorelin ships as a lyophilized (freeze-dried) solid intended for controlled laboratory reconstitution workflows.

What storage practices does NSL recommend for sealed Tesamorelin?

Keep sealed vials protected from light and humidity at approximately -4°F (-20°C) or colder; refrigeration near 39°F (4°C) is only for short holding periods consistent with your SOP.

Which catalog fill sizes are listed for Tesamorelin?

National Science Labs lists Tesamorelin as available in multiple vial sizes.

Is Tesamorelin Peptide sold as a prescription product?

No prescription pathway applies. Tesamorelin is offered strictly for research use only through the National Science Labs catalog.

How does National Science Labs fulfill shipments of Tesamorelin?

Orders ship in protective packaging selected to preserve vial integrity in transit. Shipping details: https://www.nationalsciencelabs.co/shipping/

Where can laboratories review quality documentation for Tesamorelin?

Batch quality is supported with third-party testing and Certificates of Analysis when available. Review COA resources: https://www.nationalsciencelabs.co/coa/